QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trials

Search Clinical Trials By:

Pediatrics

Showing 1 to 3 of 3
<<
1 - 3
>>
Clinical Trials
A Four-Year Blinded-Outcomes Follow-up Study of Patients Who Received Stannsoporfin or Placebo in Clinical Trial 64,185-204 (A 48-52 Month Blinded-Outcomes Follow-up Study of Patients Having Received Stannsoporfin or Placebo in Clinical Trial 64,185-205)
DANCE: An open-label, single arm study to evaluate the week 48 efficacy and safety of a two-drug regimen of dolutegravir/lamivudine (DTG/3TC) as a fixed dose combination (FDC), in antiretroviral therapy (ART)-naïve HIV-1-infected adolescents, >12 to <18 years of age who weight at least 40kg
Gilead GS-US-380-1474: A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/ Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1 Infected Virologically Suppressed Adolescents and Children
Keywords: HIV, HIV medications

News & Announcements

Upcoming Events

Aug 19

HIV Prevention in the 21st century

From 8:30 AM until 9:30 AM

Aug 21

Management of Congenital Ear Deformities

From 7:45 AM until 9:00 AM

Sep 9

CARD Constituency Board Meeting

From 9:30 AM until 10:30 AM